Overview
Uzma Iqbal is a Hematologist Oncology specialist and a Hematologist in Houston, Texas. Dr. Iqbal is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Aplastic Anemia, and Thrombocytopenia.
Her clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Baylor College Of Medicine
Mothaffar Rimawi is a Hematologist Oncology specialist and a Hematologist in Houston, Texas. Dr. Rimawi is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Paget Disease of the Breast. Dr. Rimawi is currently accepting new patients.
MD Anderson
Bora Lim is an Oncologist and a Hematologist in Houston, Texas. Dr. Lim is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and Tissue Biopsy.
Gabriel Hortobagyi is an Oncologist in Houston, Texas. Dr. Hortobagyi is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Breast Cancer in Men.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Iqbal isDistinguished. Learn about Breast Cancer.
- Paget Disease of the BreastDr. Iqbal isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Aplastic AnemiaDr. Iqbal isAdvanced. Learn about Aplastic Anemia.
- Childhood Iron Deficiency Anemia
- Iron Deficiency AnemiaDr. Iqbal isAdvanced. Learn about Iron Deficiency Anemia.
- ThrombocytopeniaDr. Iqbal isAdvanced. Learn about Thrombocytopenia.
- Experienced
- Acute Mountain SicknessDr. Iqbal isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Iqbal isExperienced. Learn about Adult Immune Thrombocytopenia.
- AnemiaDr. Iqbal isExperienced. Learn about Anemia.
- AngiosarcomaDr. Iqbal isExperienced. Learn about Angiosarcoma.
- Autoimmune Hemolytic AnemiaDr. Iqbal isExperienced. Learn about Autoimmune Hemolytic Anemia.
- BRCA Positive Breast CancerDr. Iqbal isExperienced. Learn about BRCA Positive Breast Cancer.